510(k) K260221

Elecsys EBV EBNA IgG by Roche Diagnostics — Product Code LSE

K260221 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Elecsys EBV EBNA IgG". The FDA issued a decision of Substantially Equivalent on Oct 2, 2026. The device falls under product code LSE (Epstein-Barr Virus, Other), a Class I device regulated under 21 CFR 866.3235. Roche Diagnostics has 456 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Oct 2, 2026
Date Received
Jan 26, 2026
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Epstein-Barr Virus, Other
Device Class
Class I
Regulation Number
866.3235
Review Panel
MI
Submission Type
510(k)

Need the full FDA record for Roche Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K260221. Report a data issue: hello@regdatalab.com.